Ubs Asset Management Americas Inc 10x Genomics, Inc. Transaction History

Ubs Asset Management Americas Inc

  • $345 Billion
  • Q2 2024

A detailed history of Ubs Asset Management Americas Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 1,926,483 shares of TXG stock, worth $31.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,926,483
Previous 134,681 1330.4%
Holding current value
$31.5 Million
Previous $5.05 Million 641.39%
% of portfolio
0.01%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$19.45 - $37.37 $34.9 Million - $67 Million
1,791,802 Added 1330.4%
1,926,483 $37.5 Million
Q1 2024

May 15, 2024
BUY
$36.08 - $54.3 $61,949 - $93,233
1,717 Added 1.29%
134,681 $5.05 Million
Q4 2023

Feb 14, 2024
SELL
$34.32 - $57.55 $26,666 - $44,716
-777 Reduced 0.58%
132,964 $7.44 Million
Q3 2023

Nov 13, 2023
SELL
$40.86 - $62.98 $12,258 - $18,894
-300 Reduced 0.22%
133,741 $5.52 Million
Q1 2023

May 15, 2023
BUY
$35.33 - $55.79 $195,940 - $309,411
5,546 Added 4.32%
134,041 $7.48 Million
Q4 2022

Feb 14, 2023
SELL
$24.4 - $41.3 $24,839 - $42,043
-1,018 Reduced 0.79%
128,495 $4.68 Million
Q3 2022

Nov 14, 2022
SELL
$28.48 - $52.59 $9.39 Million - $17.3 Million
-329,829 Reduced 71.8%
129,513 $3.69 Million
Q2 2022

Aug 12, 2022
SELL
$36.95 - $82.41 $3.53 Million - $7.86 Million
-95,411 Reduced 17.2%
459,342 $20.8 Million
Q1 2022

May 16, 2022
BUY
$55.7 - $145.79 $3.21 Million - $8.4 Million
57,624 Added 11.59%
554,753 $42.2 Million
Q4 2021

Feb 14, 2022
SELL
$135.05 - $182.59 $4.21 Million - $5.69 Million
-31,151 Reduced 5.9%
497,129 $74.1 Million
Q3 2021

Nov 15, 2021
BUY
$145.58 - $192.14 $1.5 Million - $1.98 Million
10,327 Added 1.99%
528,280 $76.9 Million
Q2 2021

Aug 16, 2021
BUY
$134.22 - $202.37 $2.72 Million - $4.1 Million
20,239 Added 4.07%
517,953 $101 Million
Q1 2021

May 14, 2021
SELL
$140.25 - $196.86 $17.3 Million - $24.3 Million
-123,394 Reduced 19.87%
497,714 $90.1 Million
Q4 2020

Mar 01, 2021
BUY
$126.47 - $163.7 $22.8 Million - $29.6 Million
180,577 Added 40.99%
621,108 $87.9 Million
Q3 2020

Nov 13, 2020
BUY
$87.44 - $125.0 $3.95 Million - $5.64 Million
45,150 Added 11.42%
440,531 $54.9 Million
Q2 2020

Aug 14, 2020
BUY
$58.39 - $89.31 $1.89 Million - $2.89 Million
32,389 Added 8.92%
395,381 $35.3 Million
Q1 2020

May 15, 2020
BUY
$51.57 - $106.62 $26,042 - $53,843
505 Added 0.14%
362,992 $22.6 Million
Q4 2019

Feb 14, 2020
BUY
$46.07 - $79.54 $8.19 Million - $14.1 Million
177,804 Added 96.28%
362,487 $27.6 Million
Q3 2019

Nov 14, 2019
BUY
$49.99 - $62.0 $9.23 Million - $11.5 Million
184,683 New
184,683 $9.31 Million

Others Institutions Holding TXG

# of Institutions
285
Shares Held
97.2M
Call Options Held
162K
Put Options Held
107K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.55B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email